ID93 clinical trials
How each study uses ID93 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ID93 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 6
Access to Advanced Health Institute (AAHI) (4) · Quratis Inc. (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test ID93.
- Jul 2027ID93/GLA-SE Vaccination + BCG ChallengeNot applicable · University of Oxford
Studies
Open first, then newest update. How each study uses ID93 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- ID93/GLA-SE Vaccination + BCG ChallengeRecruitingNot applicableUniversity of OxfordNCT06670755Written as ID93/GLA-SE
- Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy AdultsCompletedPhase 1Access to Advanced Health Institute (AAHI)NCT03722472Written as ID93 + GLA-SE
- Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy AdolescentStatus unknownPhase 1Quratis Inc.NCT03806699Written as ID93+GLA-SE
- Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare WorkersStatus unknownPhase 2Quratis Inc.NCT03806686Written as ID93+GLA-SE
- Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment CompletionCompletedPhase 2Access to Advanced Health Institute (AAHI)NCT02465216Written as ID93 + GLA-SE
- Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult VolunteersCompletedPhase 1Access to Advanced Health Institute (AAHI)NCT01927159Written as ID93 + GLA-SE
- Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult SubjectsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02508376Written as ID93
- Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedPhase 1Access to Advanced Health Institute (AAHI)NCT01599897Written as ID93 + GLA-SE